Isoenzymes of protein kinase C: Differential involvement in apoptosis and pathogenesis

Journal of Clinical Pathology - Molecular Pathology

Volumn 50, Issue 3, 1997, Pages 124-131

  Deacon, E M ^a   Pongracz, J ^a   Griffiths, G ^a   Lord, J M ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISOENZYME; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL ESTER; PROTEIN KINASE C; PROTEIN SERINE THREONINE KINASE; STAUROSPORINE;

ATAXIA TELANGIECTASIA; CARCINOGENESIS; CELL DEATH; CELL PROLIFERATION; ENZYME ACTIVATION; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0030721001     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.50.3.124     Document Type: Review

References (140)

1. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57.
2. Wyllie AH. Glucocorticoid induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980;284:555-6.
3. Savill J, Fadok V, Henson P, Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol Today 1993;14: 131-6.
4. Kerr JFR, Harmon B, Searle J. An electron-microscope study of cell deletion in the anuran tadpole tail during spontaneous meta-morphosis with special reference to apoptosis of striated muscle libres. J Cell Sci 1974;14:571-85.
5. Kerr JFR, Searle J, Harmon BV, Bishop CJ. Apoptosis. In: Potten CS, ed. Perspectives on mammalian cell death. Oxford: Oxford Science Publications, 1987:93-128.
6. Smith CA, Williams GT, Kingston RT, Jenkinson R, Jenkinson, EJ, Owen JJT. Antibodies to CD3/T receptor complex induce death by apoptosis in immature thymic cultures. Nature 1989;337:181-4.
7. Savill JS, Wyllie AH, Henson JE, Walport MJJ, Henson PM, Haslett C. Macrophage phagocytosis of ageing neutrophils inflammation. Programmed cell death in the neutrophil leads to recognition by macrophages. J Clin Invest 1989;83: 865-75.
8. Williams GT. Programmed cell death: apoptosis and carcinogenesis. Cell 1991;65:1097-8.
9. Dive C, Hickman JA. Drug-target interactions - only the first step in the commitment to a programmed cell-death. Br J Cancer 1991;64:192-6.
10. Fisher DE. Apoptosis in cancer therapy: crossing the threshold. Cell 1994;78:539-42.
11. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, DeLong MR. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 1982;215:1237-46.
12. Martin JB. Huntingdons disease: genetically programmed cell death in the human central nervous system. Nature 1982;299:205-8.
13. Grigg JM, Savill JS, Sarraf C, Haslett C, Silverman M. Neutrophil apoptosis and clearance from neonatal lungs. Lancet 1991;338:720-2.
14. Bursch W, Oberhammer F, Schulte-Hermann R. Cell death by apoptosis and its protective role against disease. Trends Pharmacol Sci 1992;13:245-51.
15. Groux H, Torpier G, Monte D, Mouton Y, Capron A, Ameisen JC. Activation-induced death by apoptosis in CD4+ T cells from human-immunodeficiency-virus infected asymptomatic individuals. J Exp Med 1992;175: 331-40.
16. Kerr JFR, Winterford CM, Harmon BV. Apoptosis its significance in cancer and cancer therapy. Cancer 1994;73: 2013-26.
17. Gescher A. Towards selective pharmacological modulation of protein-kinase C - opportunities for the development of novel antineoplastic agents. Br J Cancer 1992;66:10-19.
18. Nishizuka Y. Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992;258:607-14.
19. Hug H, Sarre TF. Protein kinase C isoenzymes: divergence in signal transduction? Biochem J 1993;291:329-43.
20. Inoue M, Kishimoto A, Takai Y, Nishizuka Y. Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissue. II. Proenzyme and its activation by calcium-dependent proteases from rat brain. J Biol Chem 1977;252:7610-16.
21. 2+-phospholipid-dependent protein kinase in rat islets and hamster β-cells. Biochem J 1984;219:547-51.
22. Jaken S, Leach K, Kiauck T. Association of type 3 protein kinase C with focal contacts in rat embryo fibroblasts. J Cell Biol 1989;109:697-704.
23. Murti KG, Kaur K, Goorha RM. Protein kinase C associated with intermediate filaments and stress fibres. Exp Cell Res 1992;202:36-44.
24. Owen PJ. Protein kinase C-delta associates with vimentin intermediate filaments in differentiated HL60 cells. Exp Cell Res 1996;225:366-73.
25. Barry ST, Critchley DR. The Rho A-dependent assembly of focal adhesions in Swiss 3T3 cells is associated with tyrosine phosphorylation and the recruitment of both PP125 FAK and protein kinase C-delta to focal adhesions. J Cell Sci 1994;107:2033-45.
26. Berry N, Nishizuka Y. Protein kinase C and T cell activation. Eur J Biochem 1990;189:205-14.
27. Baudier J, Delphin C, Grunwald D, Knochbin S, Lawrence JJ. Character isolation of the tumour suppressor protein p53 as a protein kinase C substrate and an s100b binding protein. Proc. Natl Acad Sci USA 1992;89:11627-31.
28. Li L, Zhou J, James G, Heller-Harrison R, Czech MP, Olson EN. FGF inactivates helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA binding domains. Cell 1992;71:1181-94.
29. Lotem J, Cragoe EJ, Sachs L. Rescue from programmed death in leukaemic and normal myeloid cells. Blood 1991;78:953-60.
30. Pongracz J, Johnson GD, Crocker J, Burnett D, Lord JM. The role of protein kinase C in myeloid cell apoptosis. Biochem Soc Trans 1994;22:593-7.
31. Lucas M, Sanchez-Margalet V. Protein kinase C involvement in apoptosis. Gen Pharmacol 1995;26:881-7.
32. Parker PJ, Kour G, Marais RM, Mitchell F, Pears C, Schaap D, et al. Protein kinase C a family affair. Mol Cell Endocrinol 1989;65:1-11.
33. Dekker LV, Parker PJ. Protein kinase C a question of specificity. Trends Biochem Sci 1994;19:73-7.
34. Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 1984;308: 693-8.
35. Wada H, Ohno S, Hubo K, Taya C, Tsuji S, Yonehara S, et al. Cell type-specific expression of the genes for the protein kinase C family: Down-regulation of mRNAs for the PKC-α and PKC-ε upon in vitro differentiation of a mouse neuroblastoma cell line neuro 2a. Biochem Biophys Res Comm 1989;165:533-8.
36. Wetsel WC, Khan WA, Merchenthaler I, et al. Tissue and cellular distribution of the extended family of protein kinase C isoenzymes. J Cell Biol 1992;117:121-33.
37. Nishizuka Y. The molecular heterogenity of protein kinase C in cell surface signal transduction and tumour promotion. Nature 1988;334:661-5.
38. Osada S, Muzuno K, Saido TC, Suzuki K, Kuroki T, Ohno S. A new member of the protein kinase C family, nPKC0, predominately expressed in skeletal muscle. Mol Cell Biol 1992;12:3930-8.
39. Goodnight J, Mishak H, Mushinski JF. Selective involvement of protein kinase C in differentiation and neoplastic transformation. Adv Cancer Res 1994;64:159-209.
40. Newton AC. Protein kinase C: structure, function, and regulation. J Biol Chem 1995;270:28495-8.
41. Lozano J, Berra E, Municio MM, Diazmeco MT, Dominguez I, Sanz L, et al. Protein kinase C-ζ is critical for NF-κB-dependent promoter activation by sphingomelinase. J Biol Chem 1994;269:19200-2.
42. Muller G, Ayoub M, Storz P, Rennecke J, Fabbro D, Pfizenmaier K. PKC ζ is a molecular switch in signal transduction of TNF-α, bifunctionally regulated by ceramide and arachidonic acid. EMBO J 1995;14:1961-9.
43. Nakanishi H, Brewer KA, Exton JH. Activation of the ζ-isozyme of protein kinase C by phospatidylinositol 3,4,5-triphosphate. J Biol Chem 1993;268:13-16.
44. Kishimoto A, Kajikawa N, Shiota M, Nishizuka Y. Proteolytic activation of calcium activated, phospholipid dependent neutral protease. J Biol Chem 1983;258:1156-64.
45. Kikkawa U, Ogita K, Shearman MS, Ase K, Sekiguchi K, Naor Z, et al. The family of protein kinase-C its molecular heterogeneity and differential expression. Cold Spring Harbor Symp Quant Biol 1988;53:97-102.
46. Lee MH, Bell RM. Mechanism of protein-kinase-C activation by phosphatidylinositol 4,5 biphosphate. Biochemistry 1991;30:1041-9.
47. Divecha N, Banfic H, Irvine RF. The polyphosphoinositide cycle exists in the nuclei of Swiss 3T3 cells under the control of a receptor (for IGF-1) in the plasma-membrane, and stimulation of the cycle increases nuclear diacylglycerol and apparently induces translocation of protein kinase-C to the nucleus. EMBO J 1991;10:3207-14.
48. Hocevar BA, Fields AP. Selective translocation of βII PKC to the nucleus of human promyelocytic (HL60) leukaemia cells. J Biol Chem 1991;266:28-33.
49. Kiley S, Jaken S, Whelan R, Parker PJ. Intracellular targeting of protein kinase C isoenzymes functional implications. Biochem Soc Trans 1995;23:601-5.
50. Nakamura SI, Nishizuka Y. Lipid mediation and protein kinase C activation for the intracellular signalling network. J Biochem 1994;115:1029-34.
51. Khan W, Blobe GC, Hannun YA. Arachidonic acid and free fatty acids as second messengers and the role of protein kinase C. Cellular Signalling 1995;7:171-84.
52. Nishizuka Y. Protein kinase C 5: protein kinase C and lipid signalling for sustained cellular responses. FASEB J 1995; 9:484-96.
53. Lee JY, Hannun YA, Obeid LM. Ceramide inactivates cellular protein kinase C-alpha. J Biol Chem 1996;271:13169-74.
54. Pettit TR, Zaqqa M, Wakelam MJO. Epidermal growth factor stimulates distinct diacylglcerol species generation in Swiss 3T3 fibroblasts - evidence for a potential phosphatidylcholine-specific phospholipase C catalyzed pathway. Biochem J 1994;298:655-60.
55. 2+-dependent to an independent form of phorbol ester binding protein by digestion with trypsin. Biochem Biophys Res Comm 1986;139:320-6.
56. Schaap D, Husan JM, Totty N, Parker PJ. Proteolytic activation of PKC-epsilon. Eur J Biochem 1990;191:431-5.
57. Kishimoto A, Mikawa IL, Hashimoto K, Vasuda I, Tanaka SI. Limited proteolysis of protein kinase C subspecies by calcium dependent neutral protease (calpain). J Biol Chem 1989;204:4088-92.
58. 2+, phosphatidyl inositol and phosphatidyl inositol 4,5 biphosphate. Biochem J 1993; 291:627-33.
59. Emoto Y, Kisaki H, Manome Y, Kharbanda S, Kaife D. Activation of protein kinase C δ in human myeloid leukaemia cells treated with 1-β-arabinofuranosylcytosine. Blood 1996;87:1990-6.
60. Berra E, Diaz Meco MT, Lozano J, Frutos S, Municio MM, Sanchez P, et al. Evidence for a role of MEK and MAPK during signal transduction by protein kinase C-zeta. EMBO J 1995;14:6157-63.
61. Sahyoun N, Wolf M, Besterman J, Hsieh TS, Sander M, Levine H, et al. Protein kinase C phosphorylates DNA topoisomerase II: topoisomerase activation and its possible role in phorbol ester-induced differentiation of HL60 cells. Proc Natl Acad Sci USA 1986;83:1603-7.
62. Bauer PI, Farkas G, Buday L, Mikala G, Meszaros G, Kun E, et al. Inhibition of DNA binding by the phosphorylation of poly ADP-ribose polymerase protein catalysed by protein kinase C. Biochem Biophys Res Comm 1992;187: 730-6.
63. Goss VL, Hocevar BA, Thompson LJ, Stratton CA, Burns DJ, Fields AP. Identification of nuclear βII protein kinase C as a mitotic lamin kinase. J Biol Chem 1994;269:19074-80.
64. Thompson LJ, Fields AP. Beta (II) protein kinase C is required for the G(2)/M phase-transition of cell cycle. J Biol Chem 1996;271:15045-53.
65. Moore NC, Jenkinson EJ, Owen JJ. Effects of the thymic microenvironment on the response of thymocytes to stimulation. Eur J Immunol 1992;22:2533-7.
66. Powell CT, Brittis NJ, Stec D, Hug H, Heston WDW, Fair WR. Persistent membrane translocation of protein kinase C alpha during 12-0-tetradecanoylphorbol-13-acetate-induced apoptosis of LNCAP human prostate cancer cells. Cell Growth Diff 1996;7:419-28.
67. Brooks G, Wilson RF, Dooley TP, Goss MW, Hart IR. Protein kinase-C down-regulation, and not transient activation, correlates with melanocyte growth. Cancer Res 1991;51:3281-8.
68. 2+-independent phorbol ester receptor. J Biol Chem 1990;265:15704-12.
69. Pongracz J, Tuffley W, Johnson GD, Deacon EM, Burnett D, Stockley RA, et al. Changes in protein kinase C isoenzyme expression associated with apoptosis in U937 myelomonocytic cells. Exp Cell Res 1995;218:430-8.
70. Macfarlane DE, O'Donnell PS. Phorbol ester induces apoptosis in HL60 promyelocytic leukemia cells but not in HL60 PET mutant. Leukaemia 1993;7:1846-51.
71. Knox KA, Johnson GD, Gordon J. A study of protein kinase C isoenzyme distribution in relation to Bcl-2 expression during apoptosis of epithelial cells in vivo. Exp Cell Res 1993;207:68-73.
72. Ryves WJ, Evans AT, Olivier AR, Parker PJ, Evans FJ. Activation of the PKC isotypes α, β1, γ, δ and ε by phorbol esters of different biological activities. FEBS Lett 1991;288: 5-9.
73. MacFarlane DE, Manzel L. Activation of β-isozyme of protein kinase C (PKC-β) is necessary and sufficient for phorbol ester-induced differentiation ot HL60 promyelocytes. J Biol Chem 1994;269:4327-31.
74. Pongracz J, Deacon EM, Johnson GD, Burnett D, Lord JM. Doppa induces cell death hut not differentiation of U937 cells: evidence for the involvement of PKC-beta-1 in the regulation of apoptosis. Leukemia Res 1996;20:319-26.
75. Kvans CA, Lord JM, Owenlynch PJ, Johnson G, Dive C, Whetton AD. Suppression of apoptosis by v-ABL protein-tyrosine kinase is associated with nuclear translocation and activation of protein-kinase-C in an interleukin-3-dependent hematopoietic cell line. J Cell Sci 1995;108: 2591-8.
76. Murray NR, Baumgardner GP, Burns DJ, Fields AP. Protein kinase C isotypes in human erythroleukaemia (K562) cell proliferation and differentiation. Evidence that βII protein kinase C is required for proliferation. J Biol Chem 1993;268:15847-53.
77. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992;89:119-28.
78. Leszczynski D. The role of protein kinase C in regulation of apoptosis: a brief overview ot the controversy. Cancer J 1996;9:308-13.
79. Lazebnik YA, Cole S, Cooke CA, Nelson WG, Farnshaw WC. Nuclear events of apoptosis in vitro cell free mitotic extracts: a model system tor analysis of the active phase of apoptosis. J Cell Biol 1993;123:7-22.
80. Emoto Y, Manome Y, Meinhardt G, Kisaki H, Kharbanda S, Robertson M, et al. Proteolytic activation of protein kinase C δ by an ICE-like protease in apoptotic cells. EMBO J 1995;14:6148-56.
81. Ghayur T, Hugzunin M, Talanian RV, Ratnofsky S, Quinlan C, Emoto Y, et al. Proteolytic activation of protein kinase C delta by an ICE/CED 3-like protease induces characteristics of apoptosis. J Exp Med 1996;184:2399-404.
82. Datta R, Banach D, Kojuma H, Talanian RV, Alnemri ES, Wong WW, et al. Activation of the CPP32 protease in apoptosis induced by 1-β-D-arabinofuranosylcytosine and other DNA-damaging agents. Blood 1996;88:1936-43.
83. Griffiths G, Garrone B, Deacon E, Owen P, Pongracz J, Mead G, et al. The polyether bistratene A activates protein kinase C-delta and induces growth arrest in HL60 cells. Biochem Biophys Res Comm 1996;222:802-8.
84. Song QZ, Baxter GD, Kovacs EM, Findik D, Lavin MF. Inhibition of apoptosis in human tumour cells by okadaic acid. J Cell Physiol 1992;153:550-6.
85. Lord JM, Garrone B, Griffiths G, Watters D. Apoptosis induced by Bistratene A in HL60 cells involves the selective activation of PKC-delta and its association of nuclear lamins and DNA replication sites [abstract]. J Cell Biochem 1995;S19B:275.
86. Watanabe T, Ono Y, Taniyama Y, Hazama K, Igarashi K, Ogita K, et al. Cell division arrest induced by phorbol ester in CHO cells overexpressing protein kinase C delta. Proc Natl Acad Sci USA 1992;84:10159-63.
87. Neamati N, Fernandez, A, Wright S, Kiefer J, McConkney DJ. Degradation of lamin B-1 precedes oligonucleosomal DNA fragmentation in apoptotic thymocytes and isolated thymocyte nuclei. J Immunol 1995;154:3788-95.
88. Oberhammer FA, Hochegger K, Froschl G. Chromatin condensation during apoptosis is accompanied by degradation of lamin A and B, without enhanced activation of cdc2 kinase. J Cell Biol 1994;126:827-37.
89. Takahashi A, Alnemri ES, Lazenbik YA, Fernandesalnemri T, Litwack G, Moir RD, et al. Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc Natl Acad Sci USA 1996;93:8395-400.
90. Shi L, Nishioka WK, Thng J, Bradbury EM, Litchfield DW, Greenburgh AH. The premature P34 (cdc2) activation required for apoptosis. Science 1994;263:1143-5.
91. Leszczynski D, Joenvaara S, Foegh ML. Apoptosis of rat vascular smooth muscle cells is regulated by δ and ζ but not by α and ε isozymes of protein kinase C [abstract]. Mol Biol Cell 1995;6(suppl):246a.
92. Obeid LM, Linardic CM, Karolak LA, Hannun YA. Programmed cell death induced by ceramide. Science 1993;259:1769-71.
93. Jarvis WD, Kolesnick RN, Fornari FA, Taylor RS, Gerwitz DA, Grant S. Induction of apoptotic DNA fragmentation and cell death by activation of the sphingnomyelin pathway. Proc Natl Acad Sci USA 1994,91:73-7.
94. Chmura SJ, Nodzenski E, Weichselbaum RR, Quintans J. Protein-kinase-C inhibition induces apoptosis and ceramide production through activation of a neutral sphingomyelinase. Cancer Res 1996;56:2711-14.
95. Jarvis WD, Grant S, Kolesnick RN. Ceramide and induction of apoptosis. Clin Cancer Res 1996;2:1-6.
96. Mathias S, Dressler KA, Kolesnick RN. Characterization of a ceramide-activated protein kinase: stimulation by tumour necrosis factor-alpha. Proc Natl Acad Sci USA 1991;88: 10009-13.
97. Dobrowsky RT, Hannun YA. Ceramide stimulates a cytosolic protein phosphatase-activity. J Biol Chem 1992; 267:5048-51.
98. Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso OA, Gutkind JS, et al. Suppression of ceramide-mediated programmed cell-death by shingosine-1-phosphate. Nature 1996;381:800-3.
99. Diazmeco MT, Municio MM, Frutos S, Sanchez P, Lozano J, Sanz L, et al. The product of PAR-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein-kinase C. Cell 1996;86:777-86.
100. Yousefi S, Dibbert B, Blaser K, Simon HU. Inhibition of eosinophil apoptosis in chronic allergic disease [abstract]. Cell Death Diff 1996;3:443.
101. Coxon A, Barkalow FJ, Askari S, Rieu P, Sharpe AH, Vonandrian U, et al!. A novel role for the beta(2) integrin CD11B/CD18 in neutrophil apotosis [abstract]. J Leukocyte Biol 1996;SS:307.
102. Jenner P, Olanow CW. Oxidative stress and the pathogenesis of Parkinsons-disease. Neurology 1996;47:S161-70.
103. Hamet P, Deblois D, Dam TV, Richard L, Teiger E, Tea BS, et al. Apoptosis and vascular wall remodelling in hypertension. Can J Physiol Pharmacol 1996;74:850-1.
104. Gougeon ML. Apoptosis in AIDS -genetic control and relevance for AIDS pathogenesis. Biochem Soc Trans 1996; 24:1055-8.
105. Battaini F, Leggio A, Govoni S, Frattola L, Appollonio I, Ferrarese C, et al. Decrease in phorbol ester receptors in human brain tumours. Eur Neurol 1990;30:241-6.
106. Chachin M, Shimohama S, Kunugi YU, Taniguchi T Assessment of protein kinase C messenger-RNA levels in Alzheimers disease brains. Jpn J Pharmacol 1996;71:175-7.
107. 2+-independent protein kinase C changes in the brains of patients with Alzheimers-disease. J Neurochem 1996;67:317-23.
108. Greenwood AF, Powers RE, Jope RS. Phosphoinositide hydrolysis, G-alpha-Q, phospholipase C, and protein kinase C in post-mortem interval, subject age, and Alzheimers disease. Neuroscience 1996;69:125-38.
109. Govoni S, Racchi M, Bergamaschi S, Trabucchi M, Battaini F, Bianchetti A, et al. Defective protein kinase C-alpha leads to impaired secretion of soluble beta-amyloid precursor protein from Alzheimers-disease fibroblasts. Ann NY Acad Sci 1996;777:332-7.
110. Bergamaschi S, Binetti G, Govoni S, Wetsel WC, Battaini F, Trabucchi M, et al. Defective phorbol ester-stimulated secretion of beta-amyloid precusor protein from Alzheimers-disease fibroblasts. Neuroseicnce Lett 1995;201: 1-4.
111. Curnutte JT, Erickson RW, Ding JB, Badwey JA. Reciprocal interactions between protein kinase C and components of the NADPH oxidase complex may regulate Superoxide production by neutrophils stimulated with phorbol ester. J Biol Chem 1994;269:10813-19.
112. Pongracz J, Deacon EM, Lord JM. Activation versus apoptosis in neutrophils: differential involvement of PKC isoenzymes [abstract]. J Cell Biochem 1995;S19B:291.
113. Battisti C, Formichi P, Federico A. Vitamin-E serum levels are normal in ataxia-telangiectasia (Louis-Bar disease). J Neurol Sci 1996;141:114-16.
114. Lavin MF, Khanna KK, Beamish H, Teale B, Hobson K, Watters D. Defect in radiation signal transduction in ataxia telangiectasia. Int J Rad Biol 1995;66:5151-6.
115. Lord JM, Pongracz J. Protein kinase C: a family of isoenzymes with distinct roles in pathogenesis. J Clin Pathol Mol Pathol 1995;48:M57-64.
116. Mischak H, Goodnight J, Kolch W, Martinybaron G, Schaechtle C, Kazanietz MG, et al. Overexpression of protein kinase-C-delta and kinase-epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence and tumorigenicity. J Biol Chem 1993;268: 6090-6.
117. Watson J, Littlebury P, Rumsby M. Is synthesis of protein kinase C-epsilon under translational control in 3T3 and 3T6 fibroblasts [abstract]. Immunology 1996;89:G74.
118. Li YK, Davis KL, Sytkowski AJ. Protein-kinase C-epsilon is necessary for erythropoietins up-regulation of c-myc and for factor dependent DNA synthesis evidence for discrete signals for growth and differentiation. J Biol Chem 1996;271:27025-30.
119. Perletti GP, Foloni M, Lin HC, Mischak H, Piccinini F, Tashjian AH. Overexpression of protein kinase C-epsilon is oncogenic in rat colonic epithelial cells. Oncogene 1996;12: 847-54.
120. Manni A, Buckwalter E, Etindi R, Kunselman S, Rossini A, Mauger D, et al. Induction of a less aggressive breast-cancer phenotype by protein kinase C-alpha and C-beta overexpression. Cell Growth Diff 1996;7:1187-98.
121. Hrzenjak M, Shain SA. Protein-kinase-C-dependent and protein-kinase-C-independent pathways of signal-transduction in prostate cancer cells fibroblast growth-factor utilization of a protein kinase C-independent pathway. Cell Growth Diff 1995;6:1129-42.
122. Pongracz J, Clark P, Neoptolemous JP, Lord JM. Expression of protein kinase C isozymes in colorectal cancer tissue and their differential activation by different bile acids. Int J Cancer 1995;61:35-9.
123. Kiss Z, Anderson WH. Selective down-regulation of protein kinase C-epsilon by carcinogens does not prevent stimulation of phospholipase D by phorbol ester and platelet-derived growth-factor. Biochem J 1994;300:751-6.
124. Rusnak JM, Lazo JS. Downregulation of protein kinase C suppresses induction of apoptosis in human prostatic carcinoma cells. Exp Cell Res 1996;224:189-99.
125. Yazaki T, Ahmad S, Chahlavi A, Zylberkatz E, Dean NM, Rabkin SD, et al. Treatment of glioblastoma U-87 by systemic administration of an antisense protein-kinase C-alpha phosphorothioate oligodeoxynucleotide. Mol Pharmacol 1996;50:236-42.
126. Ways D, Kukoly J, de Vente J, Hooker JL, Bryant WO, Posekany KJ, et al. MCF-7 breast cancer cells transfected with protein kinase C-α exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype. J Clin Invest 1995;95:1906-15.
127. Kariya K, Karns LR, Simpson PC. Expression of a constitutively activated mutant of the beta-isozyme of protein kinase C in cardiac myocytes stimulates the promoter of the beta-myosin heavy-chain isogene. J Biol Chem 1991; 266:10023-6.
128. Decock JBJ, Gillespiebrown J, Parker PJ, Sugden PH, Fuller SJ. Classical, novel and atypical isoforms of PKC stimulate ANF-regulated-promoter and TRE AP-1-regulated-promoter activity in ventricular cardiomyocytes. FEBS Lett 1994;356:275-8.
129. Rodriguez-Tarducy G, Lopez-Rivas A. Phorbol esters inhibits apoptosis in IL-2-dependent T lymphocytes. Biochem Biophys Res Comm 1989;164:1069-75.
130. Iseki R, Mukai M, Iwata M. Regulation of lymphocyte-T apoptosis - signals for the antagonism between activation-induced and glucocorticoid-induced death. J Immunol 1991;147:4286-92.
131. Craven PA, DeRubertis FR. Loss of protein kinase C-δ isozyme immunoreactivity in human adenocarcinomas. Dig Res Sci 1994;39:481-9.
132. Gordge PC, Hulme JJ, Clegg RA, Muller WR. Elevation of protein kinase A and protein kinase C activity in malignant compared with normal human breast tissue. Eur J Cancer 1996;32A:2120-6.
133. Zhang W, Saki N, Fu T, Okano Y, Hirayama H, Takenaka K, et al. Diacylglycerol formation and DNA synthesis in endothelia-stimulated rat C6 glioma cells: the possible role of phosphatidylcholine breakdown. Neurosci Lett 1991;123: 164-6.
134. Kinter AL, Poli G, Maury W, Folks TM, Fauci AS. Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells. J Virol 1990;64: 4306-12.
135. Meurs H, Kaufman HF, Koeter GH, Timmermans A, DeVries K. Regulation of the beta-receptor adenylate cyclase system in lymphocytes of allergic patients with asthma: possible role for protein kinase C in allergen-induced non-specific refractoriness of adenylate cyclase. J Allergy Clin Immunol 1987;80:326-9.
136. Schmitz PG, Zhang K. Expression of protein kinase C alpha (PKC alpha) in the remnant kidney proposed role in potentiating glomerular capillary hypertension [abstract]. J Am Soc Nephrol 1994;5:611.
137. Vito P, Walosin B, Ganjei JK, Iwasaki K, Lacana E, Dadamio L. Requirement of the familial Alzheimers disease gene PS2 for apoptosis - opposing effect of ALG-3. J Biol Chem 1996;271:31025-8.
138. Laporte M, Galand P, Fokand D, DeGraef C, Heenen M. Apoptosis in normal skin, psoriasis and regressing psoriasis [abstract]. J Invest Dermatol 1996;106:356.
139. 2+-independent protein kinase C in normal human skin and skin diseases. J Invest Dermatol 1993;101:853-63.
140. Fisher GJ, Tavakkol A, Leach K, Burns D, Basta P, Loomis C, et al. Differential expression of protein kinase C isoenzymes in normal psoriatic adult skin-reduced expression of protein kinase C beta-II in psoriasis. J Invest Dermatol 1993;101:553-9.